Press release
Graves' Orbitopathy Market Growing at a CAGR of around 9.5% in 2034
Graves' Orbitopathy Market
The Graves' Orbitopathy (Thyroid Eye Disease) market was valued at ~USD 1.9 billion in 2024 and is expected to reach ~USD 4.8 billion by 2034, growing at a CAGR of around 9.5%. Growth is driven by rising autoimmune thyroid disorders, increasing diagnosis of orbital inflammation, and rapid adoption of targeted biologic therapies.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71315
Key Market Drivers
• Rising prevalence of Graves' disease and autoimmune thyroid disorders.
• Growing use of targeted biologics, especially IGF-1R inhibitors (e.g., Teprotumumab).
• Increased awareness among endocrinologists and ophthalmologists.
• Advancements in imaging (MRI/CT) improving early detection of orbital inflammation.
Challenges
• Extremely high treatment costs for biologic therapies.
• Limited therapeutic alternatives for moderate-severe cases.
• Delayed diagnosis in developing markets due to limited specialist access.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71315/graves-orbitopathy-market
Market Segmentation
By Treatment
• Biologic therapies
• Corticosteroids
• Immunosuppressants
• Radiotherapy
• Surgical treatment (orbital decompression)
By Type
• Active/Inflammatory Graves' Orbitopathy
• Inactive/Chronic Graves' Orbitopathy
By End User
• Hospitals
• Ophthalmology clinics
• Endocrinology centers
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71315
Regional Snapshot
• North America leads due to strong biologic adoption and high prevalence of autoimmune thyroid disease.
• Europe shows stable growth with guideline-based management and increased specialist involvement.
• Asia-Pacific is the fastest-growing region as awareness, diagnosis, and access to advanced therapies expand.
Key Companies
Horizon Therapeutics (Amgen), Roche, Novartis, Teva, Pfizer, Sanofi, AbbVie.
Future Outlook
The market will grow significantly as biologic therapies become the standard of care, supported by earlier diagnosis, multimodal treatment approaches, and improved patient management pathways. Expansion in emerging markets and new biologic approvals will accelerate future adoption.
This report is also available in the following languages : Japanese (グレーブス眼窩症市場), Korean (그레이브스 안와병증 시장), Chinese (格雷夫斯眼病市场), French (Marché de l'orbitopathie de Graves), German (Markt für Graves-Orbitopathie), and Italian (Mercato dell'orbitopatia di Graves), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71315
Our More Reports:
Sarcoidosis Market
https://exactitudeconsultancy.com/reports/71350/sarcoidosis-market
Anti-Glomerular Basement Membrane Market
https://exactitudeconsultancy.com/reports/71352/anti-glomerular-basement-membrane-market
Peanut Allergy Market
https://exactitudeconsultancy.com/reports/71354/peanut-allergy-market
Cytomegalovirus (CMV) Infections Market
https://exactitudeconsultancy.com/reports/71356/cytomegalovirus-cmv-infections-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Graves' Orbitopathy Market Growing at a CAGR of around 9.5% in 2034 here
News-ID: 4311146 • Views: …
More Releases from Exactitude Consultancy
Esophageal Achalasia Market is projected to reach USD 598 million by 2034
The global Esophageal Achalasia Market was valued at USD 345 million in 2024 and is projected to reach USD 598 million by 2034, growing at a CAGR of 5.6% from 2025 to 2034. Growth is driven by rising prevalence of esophageal motility disorders, increased adoption of minimally invasive endoscopic procedures, improvements in diagnostic modalities such as high-resolution manometry (HRM), and growing clinical preference for pneumatic dilation and peroral endoscopic myotomy…
Generalized Myasthenia Gravis (gMG) Market was valued at USD 2.4 billion in 2024 …
Generalized Myasthenia Gravis (gMG) Market Overview
The Generalized Myasthenia Gravis (gMG) market was valued at USD 2.4 billion in 2024 and is projected to reach USD 6.1 billion by 2034, growing at a CAGR of around 9.8%. Growth is driven by the rapid adoption of biologics, antibody-targeted therapies, and improved diagnostic awareness for autoimmune neuromuscular disorders.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72089
Key Market Drivers
• Rising global prevalence of autoimmune…
Emesis (Anti-Emetic) Market is projected to reach USD 11.92 billion by 2034
The global Emesis Market - focused on drugs and therapies used to prevent and treat nausea and vomiting - was valued at USD 7.46 billion in 2024 and is projected to reach USD 11.92 billion by 2034, growing at a CAGR of 4.9% during the forecast period (2025-2034). Growth is driven by rising incidence of chemotherapy-induced nausea and vomiting (CINV), postoperative nausea and vomiting (PONV), pregnancy-related emesis, motion sickness, gastrointestinal…
Chronic Plaque Psoriasis Market was valued at USD 24.5 billion in 2024 and is pr …
Chronic Plaque Psoriasis Market Overview
The Chronic Plaque Psoriasis Market was valued at USD 24.5 billion in 2024 and is projected to reach USD 43.8 billion by 2034, growing at a CAGR of around 6.2%. Growth is fueled by rising disease prevalence, strong uptake of biologics, and continuous expansion of dermatology specialty care.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71377
Key Market Drivers
• Increasing global prevalence of moderate to severe plaque psoriasis.
• Rapid…
More Releases for Graves
Graves' Disease Market New Product Development & Latest Trends
Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overproduction of thyroid hormones, through antibodies that stimulate the thyroid gland. It is among the most common thyroid-related autoimmune conditions, disproportionately affecting women between 30-60 years of age. Beyond metabolic complications such as weight loss, heat intolerance, and palpitations, Graves' disease can cause thyroid eye disease (TED), which impairs vision and quality of life.
For decades, treatment has relied on antithyroid…
Graves Ophthalmopathy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Graves Ophthalmopathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Graves Ophthalmopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Graves Ophthalmopathy Research. Learn more about…
Search for graves and burials in Minsk
If you are looking for information about the location of the grave in Minsk or other regions of Belarus, the company https://verimby.com +375293887408 (Viber); +375447498518 (WhatsApp) offers professional assistance in this important matter. We specialize in finding burial sites, providing detailed data and providing support in restoring lost ties with the past, creating a family tree, even if you are in another country.
Why can the search for graves in Belarus…
Graves' Disease Treatment Market Size, Drugs, Companies 2034 | DelveInsight
Graves' Disease Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Graves' Disease Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight's "Graves' Disease Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Graves' Disease, historical and…
Japan Graves' disease Market Size & Growth Analysis Report, 2019-2025
Japan Graves' disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country's population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave's disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in…
Global Graves Disease Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Graves Disease Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Graves Disease Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/515950/graves-disease
Market…
